Campbell & CO Investment Adviser LLC Verona Pharma PLC Transaction History
Campbell & CO Investment Adviser LLC
- $1.24 Billion
- Q4 2024
A detailed history of Campbell & CO Investment Adviser LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 7,237 shares of VRNA stock, worth $445,726. This represents 0.03% of its overall portfolio holdings.
Number of Shares
7,237
Previous 15,387
52.97%
Holding current value
$445,726
Previous $442,000
23.98%
% of portfolio
0.03%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding VRNA
# of Institutions
179Shares Held
69.9MCall Options Held
704KPut Options Held
685K-
Perceptive Advisors LLC New York, NY6.32MShares$389 Million4.75% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$344 Million12.27% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.01MShares$309 Million2.01% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx4.22MShares$260 Million2.52% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$219 Million14.95% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $3.75B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...